Early Parkinson’s sleep disorders tied to NfL biomarker in study
The presence of sleep disorders in the earliest stages of Parkinson’s disease correlated with blood levels of neurofilament light…
Articles by Lindsey Shapiro, PhD
STEM-PD Phase 1 trial advances with positive early safety findings
A Phase 1 clinical trial testing the investigational stem cell-based therapy STEM-PD in people with Parkinson’s disease has advanced…
AAN 2024: Motor function in rats restored with 3D cell therapy
TreeFrog Therapeutics’ investigational cell therapy restored motor function in a rat model of Parkinson’s disease, according to a…
Enlarged brain spaces tied to Parkinson’s dyskinesia, per study
A widening of tiny, fluid-filled spaces in certain brain regions could be used as an imaging marker of levodopa-induced…
3D brain model aims to validate specialized MRI imaging techniques
A 3D-printed, high-resolution model of the brain has been developed that will offer a promising tool for advancing research into…
Gut metabolite seen as potential Parkinson’s target: Researchers
Increasing levels of a gut metabolite — a molecule that results from the digestion of certain foods — eased neurodegeneration…
AI uses gene activity patterns to ID Parkinson’s disease pathways
An artificial intelligence (AI)-based software called NetraAI was able to separate subgroups of Parkinson’s disease patients based on their…
Embryonic stem cell transplant showing safety in 12 patients
A Phase 1/2a clinical trial evaluating TED-A9, a human stem cell-based therapy, in people with Parkinson’s disease has…
Gait adjustments with AR different than what’s expected in Parkinson’s
Visual and auditory cues delivered via an augmented reality (AR) headset were found to be feasible for adjusting gait among…
Phase 2 trial findings support larger study of CNM-Au8 for Parkinson’s
Treatment with CNM-Au8, an investigational gold nanocrystal suspension therapy, boosted energy production in the brains of people with…